Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 2581–2595 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4341 TNNT2 Gene Cardiomyopathy, Dilated Type 1D Genetic Test This test evaluates the TNNT2 gene for mutations associated with dilated cardiomyopathy type 1D.	Whole Blood (EDTA), Extracted DNA, FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TNNT2 gene"] Parameters [] Preparation [] Indications ["Individuals with suspected dilated cardiomyopathy type 1D", "Family history of TNNT2-related cardiomyopathy", "Unexplained heart failure in young individuals"] Measurement technique Confirm with laboratory Codes LOINC: 81326-5 ICD-10: I42.0 Clinical summary This test evaluates the TNNT2 gene for mutations associated with dilated cardiomyopathy type 1D.
TEST-5372 TNNT3 Gene (Arthrogryposis, Distal, Type 2B) Genetic Test This genetic test evaluates the TNNT3 gene for pathogenic variants associated with distal arthrogryposis type 2B.	Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TNNT3 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number changes"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any active illness"] Indications ["Diagnosis of distal arthrogryposis type 2B", "Familial risk assessment", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 81316-3 ICD-10: Q74.3 Clinical summary This genetic test evaluates the TNNT3 gene for pathogenic variants associated with distal arthrogryposis type 2B.
TEST-5204 TNXB Gene Ehlers-Danlos Syndrome Type 3 Genetic Test This test evaluates the TNXB gene for pathogenic variants associated with classical-like Ehlers-Danlos syndrome (clEDS). It identifies mutations causing tenascin-X deficiency.	Whole blood, extracted DNA, FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TNXB gene", "Single nucleotide variants (SNVs)", "Small indels", "Copy number variations (CNVs)"] Parameters [] Preparation [] Indications ["Clinical suspicion of classical-like Ehlers-Danlos syndrome (clEDS)", "Family history of EDS", "Genetic counseling for inherited connective tissue disorders"] Measurement technique Confirm with laboratory Codes LOINC: 100309-3 ICD-10: Q79.6 Clinical summary This test evaluates the TNXB gene for pathogenic variants associated with classical-like Ehlers-Danlos syndrome (clEDS). It identifies mutations causing tenascin-X deficiency.
TEST-4239 TOR1A Gene (DYT1) Next‑Generation Sequencing (Genetic Test This genetic test identifies mutations in the TOR1A gene, specifically the GAG deletion, associated with early-onset primary torsion dystonia (DYT1).	Peripheral Whole Blood or Dried Blood Spot (FTA Card)	21–28 Calendar Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TOR1A gene sequence", "GAG deletion (c.907_909delGAG)"] Parameters [] Preparation ["No special preparation required"] Indications ["Suspected early-onset primary torsion dystonia", "Family history of DYT1", "Genetic counselling for at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 94760-6 ICD-10: G24.1 Clinical summary This genetic test identifies mutations in the TOR1A gene, specifically the GAG deletion, associated with early-onset primary torsion dystonia (DYT1).
TEST-2033 TP53 Gene (Li-Fraumeni Syndrome) Genetic Test This genetic test evaluates the TP53 gene for pathogenic variants associated with Li-Fraumeni syndrome.	Peripheral Whole Blood (EDTA)	3–4 weeks (21–28 calendar days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline pathogenic variants in the TP53 gene", "Copy number variations (CNV) in the TP53 gene"] Parameters [] Preparation ["No specific fasting required", "Inform geneticist and primary care provider about concurrent treatments"] Indications ["Individuals with a personal or family history suggestive of Li-Fraumeni syndrome", "Early-onset cancers (e.g., sarcoma, breast cancer, brain tumor, leukemia)"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Z15.09 Clinical summary This genetic test evaluates the TP53 gene for pathogenic variants associated with Li-Fraumeni syndrome.
TEST-1310 TP53 Mutation Analysis (NGS) Test This test evaluates for mutations within the TP53 gene, a critical tumour suppressor gene.	Peripheral blood (EDTA whole blood) or bone marrow aspirate	15–18 business days	6,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline and somatic variants in the TP53 gene", "Single-nucleotide variants (SNVs)", "Small insertions and deletions", "Copy-number alterations"] Parameters [] Preparation ["No fasting or special preparation is required."] Indications ["Suspected Li-Fraumeni syndrome", "Hereditary cancer predisposition", "Somatic profiling of tumours"] Measurement technique Confirm with laboratory Codes LOINC: 21647-9 ICD-10: Z15.09 Clinical summary This test evaluates for mutations within the TP53 gene, a critical tumour suppressor gene.
TEST-3125 TP63 Gene ADULT Syndrome & Split Hand-Foot Malformation Genetic Test This test evaluates the TP63 gene for pathogenic variants associated with ADULT syndrome and split hand-foot malformation.	Peripheral Whole Blood or DBS on FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TP63 gene", "Single nucleotide variants", "Indels", "Copy number changes"] Parameters [] Preparation [] Indications ["Diagnosis of ADULT syndrome", "Diagnosis of split hand-foot malformation", "Family planning for individuals with ADULT syndrome or split hand-foot malformation", "Evaluation of individuals with characteristic clinical features"] Measurement technique Confirm with laboratory Codes LOINC: 94218-3 ICD-10: Q71.6, Q87.2 Clinical summary This test evaluates the TP63 gene for pathogenic variants associated with ADULT syndrome and split hand-foot malformation.
TEST-2862 TP63 Gene Ectrodactyly-Ectodermal Dysplasia-Cleft Lip/Palate Syndrome Type 3 (EEC3) Genetic Test This genetic test analyzes the TP63 gene to detect mutations associated with Ectrodactyly-Ectodermal Dysplasia-Cleft Lip/Palate Syndrome Type 3 (EEC3). It identifies single nucleot...	Peripheral Whole Blood (EDTA tube), Buccal Swab, or FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TP63 gene variants", "Single nucleotide variants", "Small insertions/deletions", "Copy number alterations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of recent blood transfusions"] Indications ["Suspected diagnosis of EEC syndrome type 3", "Genetic counseling for families with EEC syndrome type 3", "Prenatal diagnosis in high-risk pregnancies"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.2 Clinical summary This genetic test analyzes the TP63 gene to detect mutations associated with Ectrodactyly-Ectodermal Dysplasia-Cleft Lip/Palate Syndrome Type 3 (EEC3). It identifies single nucleotide variants, small insertions/deletions, and copy number alterations within the gene.
TEST-2651 TP63 Gene Limb-Mammary Syndrome Genetic Test This genetic test analyzes the TP63 gene to detect mutations associated with limb-mammary syndrome and related disorders.	Peripheral whole blood (EDTA tube)	3 to 4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TP63 gene"] Parameters [] Preparation [] Indications ["Suspected limb-mammary syndrome", "Family history of TP63-related disorders", "Genetic counseling for related conditions"] Measurement technique Confirm with laboratory Codes LOINC: 96613-9 ICD-10: Q87.8 Clinical summary This genetic test analyzes the TP63 gene to detect mutations associated with limb-mammary syndrome and related disorders.
TEST-2410 TP63 Gene Rapp-Hodgkin Syndrome Genetic Test This genetic test analyzes the TP63 gene to identify mutations causing Rapp-Hodgkin syndrome.	Whole Blood (EDTA) or Buccal Swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TP63 gene", "Missense, nonsense, and splice-site variants"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Clinical suspicion of ectodermal dysplasia", "Family history of Rapp-Hodgkin syndrome", "Genetic counseling for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 48018-6 ICD-10: Q82.4 Clinical summary This genetic test analyzes the TP63 gene to identify mutations causing Rapp-Hodgkin syndrome.
TEST-5776 TPI1 Gene Triosephosphate Isomerase Deficiency Genetic Test This test identifies pathogenic mutations in the TPI1 gene, confirming a diagnosis of triosephosphate isomerase deficiency.	Peripheral whole blood (EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TPI1 gene", "Exons and splice sites of the TPI1 gene"] Parameters [] Preparation ["Do not undergo blood collection within two weeks of a packed red cell transfusion.", "Never discontinue any prescribed therapy without prior consultation with your treating physician."] Indications ["Suspected triosephosphate isomerase deficiency", "Carrier screening in consanguineous families", "Prenatal diagnosis", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 81232-6 ICD-10: D55.2, E74.8, Z13.8 Clinical summary This test identifies pathogenic mutations in the TPI1 gene, confirming a diagnosis of triosephosphate isomerase deficiency.
TEST-4320 TPM1 Gene Cardiomyopathy, Dilated Type 1Y Genetic Test This test identifies pathogenic mutations within the TPM1 gene, a known cause of dilated cardiomyopathy type 1Y.	Peripheral whole blood (EDTA tube)	3–4 weeks (from sample receipt)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TPM1 gene coding region", "Pathogenic mutations in TPM1"] Parameters [] Preparation [] Indications ["Individuals with a family history of cardiomyopathy", "Individuals with early heart failure", "Individuals with unexplained sudden cardiac death"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: I42.0 Clinical summary This test identifies pathogenic mutations within the TPM1 gene, a known cause of dilated cardiomyopathy type 1Y.
TEST-4260 TPM1 Gene Sequencing for Familial Hypertrophic Cardiomyopathy Type 3 (NGS) Test This diagnostic test evaluates the entire TPM1 gene for pathogenic variants associated with familial hypertrophic cardiomyopathy type 3.	Peripheral Whole Blood (FTA Card acceptable)	15 – 20 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TPM1 gene", "Mutations affecting the tropomyosin protein"] Parameters [] Preparation ["Avoid strenuous exercise for 24 hours", "Stay hydrated", "No fasting required"] Indications ["Diagnosis of familial hypertrophic cardiomyopathy type 3", "Risk assessment for family members", "Guiding personalized cardiac management"] Measurement technique Confirm with laboratory Codes LOINC: 94212-9 ICD-10: I42.1, I42.2 Clinical summary This diagnostic test evaluates the entire TPM1 gene for pathogenic variants associated with familial hypertrophic cardiomyopathy type 3.
TEST-5420 TPM2 Gene Arthrogryposis, Distal Type 1A Genetic Test This test identifies pathogenic mutations within the TPM2 gene associated with distal arthrogryposis type 1A.	Peripheral whole blood (EDTA tube)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the TPM2 gene"] Parameters [] Preparation ["No special fasting required", "Mandatory genetic counseling session prior to sample collection"] Indications ["Suspected distal arthrogryposis type 1A", "Family history of distal arthrogryposis", "Genetic counseling for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q74.3 Clinical summary This test identifies pathogenic mutations within the TPM2 gene associated with distal arthrogryposis type 1A.
TEST-5392 TPM2 Gene Nemaline Myopathy Type 4 Genetic Test This test evaluates the TPM2 gene for pathogenic variants associated with nemaline myopathy type 4.	Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card)	3–4 Weeks (Rapid reporting available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TPM2 gene", "Copy Number Variations (CNV) in the TPM2 gene"] Parameters [] Preparation [] Indications ["Clinical suspicion of nemaline myopathy type 4", "Genetic counselling prior to pregnancy", "Testing asymptomatic siblings of affected individuals"] Measurement technique Confirm with laboratory Codes LOINC: 83113-2 ICD-10: G71.23, G71.2, G71.0 Clinical summary This test evaluates the TPM2 gene for pathogenic variants associated with nemaline myopathy type 4.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories